Alyeska Investment Group
SYNH

Alyeska Investment Group’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Alyeska Investment Group’s Portfolio SYNH Stock Details SYNH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-444,732
Closed -$20.9M – 534
2018
Q2 		$20.9M Buy
+444,732
New +$18.4M 0.19% 147
2015
Q1 		– Sell
-88,044
Closed -$2.26M – 603
2014
Q4 		$2.26M Buy
+88,044
New +$2.09M 0.04% 325

Other funds holding SYNH

AI
Advent International Boston, Massachusetts $4.24B AUM 4.24% 1-Year Est. Return
THLTP
Thomas H. Lee (THL) Partners Boston, Massachusetts $205M AUM 1.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Alyeska Investment Group's SYNH Position: Q3 2018 in Review

Alyeska Investment Group sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2018, closing a stake of 444,732 shares — an estimated $20.9M sold.

Alyeska Investment Group first reported a position in SYNH in Q4 2014 and held it in 2 quarters. The position peaked at $20.9M in Q2 2018. 240 funds tracked by Wall St. Rank hold SYNH as of Q3 2018.

  • Alyeska Investment Group reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2018 after selling out during the quarter.
  • Alyeska Investment Group sold 444,732 Syneos Health, Inc. Class A Common Stock shares in Q3 2018, an estimated $20.9M.
  • Alyeska Investment Group first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2014 and held it in 2 quarters.
  • Alyeska Investment Group's Syneos Health, Inc. Class A Common Stock position peaked at $20.9M in Q2 2018.
  • 240 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2018.

Based on Alyeska Investment Group's 13F filing for Q3 2018, filed 14 Nov 2018.